Alkermes Announces FDA Advisory Committee Recommends Approval of Vivitrol for Opioid Dependence - Drugs.com MedNews
Links shared publicly online about this topic.
- 867total visits
Alkermes Announces FDA Advisory Committee Recommends Approval of Vivitrol for Opioid Dependence - Drugs.com MedNews
View full resource at drugs.com
Most Recently Shared on September 17, 2010 at 1:14 pm By:
Alkermes Announces FDA Advisory Committee Recommends Approval of Vivitrol for Opioid Dependence: WALTHAM, Mas... http://bit.ly/awyaYT #drug
Alkermes Announces FDA Advisory Committee Recommends Approval Of VIVITROL® For Opioid Dependence
medicalnewstoday.com — “Alkermes, Inc. (NASDAQ: ALKS) announced that the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee voted 12 to 1 that VIVITROL® (naltrexone for extended-rele” View full resource at medicalnewstoday.com
Most Recently Shared on September 25, 2010 at 3:05 pm By:
MNT Pain News Pain Management and Health News
Alkermes Announces FDA Advisory Committee Recommends Approval Of VIVITROL® For Opioid Dependence http://mnt.to/3KmM #pain
Alkermes Announces FDA Advisory Committee Recommends Approval Of VIVITROL(R) For Opioid Dependence - QualityPoint Technologies
qualitypointtech.net — “Alkermes, Inc. (NASDAQ: ALKS) announced that the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee voted 12 to 1 that VIVITROL (naltrexone for extended-release injectable suspension) should be approved for the treatment of opioid dependence...” View full resource at qualitypointtech.net
Most Recently Shared on September 19, 2010 at 2:01 pm By:
Alkermes Announces FDA Advisory Committee Recommends Approval Of VIVITROL(R) For Opioid Dependence: Alkermes, Inc.... http://bit.ly/aQwbNM
Alkermes Announces FDA Advisory Committee Recommends Approval Of VIVITROL(R) For Opioid Dependence
medicalnewstoday.com — “Alkermes, Inc. (NASDAQ: ALKS) announced that the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee voted 12 to 1 that VIVITROL® (naltrexone for extended-rele” View full resource at medicalnewstoday.com
Most Recently Shared on September 19, 2010 at 1:05 pm By:
MNT Alcohol / Addict Health News
Alkermes Announces FDA Advisory Committee Recommends Approval Of VIVITROL(R) For Opioid Dependence http://mnt.to/3JZ9 #alcohol #addiction
FDA Advisory Committee recommends approval of Alkermes' VIVITROL for opioid dependence
news-medical.net — “Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee voted 12 to 1 that VIVITROL® (naltrexone for extended-release injectable suspension) should be approved for the treatment of opioid dependence.” View full resource at news-medical.net
Most Recently Shared on September 17, 2010 at 4:54 am By:
FDA Advisory Committee recommends approval of Alkermes' VIVITROL for opioid dependence: Alkermes, Inc. today annou... http://bit.ly/aga8bQ
Advertisement
